Paying users zone. Data is covered by hidden.

  • Get 1 month access to Regeneron Pharmaceuticals Inc. for $13.99, or

  • get full access to entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal
Verified by Visa MasterCard SecureCode American Express SafeKey

Regeneron Pharmaceuticals Inc. (REGN)


Enterprise Value (EV)

Difficulty: Intermediate


Current Enterprise Value (EV)

Regeneron Pharmaceuticals Inc., current enterprise value calculation

Microsoft Excel LibreOffice Calc
Current share price (P) $ hidden
No. shares of common stock outstanding hidden
USD $ in thousands
Common equity (market value) hidden
Add: Preferred Stock, $.01 par value; issued and outstanding - none (per books) hidden
Total equity hidden
Add: Capital and facility lease obligations, current portion (per books) hidden
Add: Convertible senior notes, current portion (per books) hidden
Add: Capital and facility lease obligations, excluding current portion (per books) hidden
Add: Convertible senior notes, excluding current portion (per books) hidden
Total equity and debt hidden
Less: Cash and cash equivalents hidden
Less: Marketable securities hidden
Enterprise value (EV) hidden

Based on: 10-K (filing date: 2019-02-07).


Historical Enterprise Value (EV)

Regeneron Pharmaceuticals Inc., EV calculation

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
No. shares of common stock outstanding1 hidden hidden hidden hidden hidden
Share price1, 2 (USD $) hidden hidden hidden hidden hidden
USD $ in thousands
Common equity (market value) hidden hidden hidden hidden hidden
Add: Preferred Stock, $.01 par value; issued and outstanding - none (per books) hidden hidden hidden hidden hidden
Total equity hidden hidden hidden hidden hidden
Add: Capital and facility lease obligations, current portion (per books) hidden hidden hidden hidden hidden
Add: Convertible senior notes, current portion (per books) hidden hidden hidden hidden hidden
Add: Capital and facility lease obligations, excluding current portion (per books) hidden hidden hidden hidden hidden
Add: Convertible senior notes, excluding current portion (per books) hidden hidden hidden hidden hidden
Total equity and debt hidden hidden hidden hidden hidden
Less: Cash and cash equivalents hidden hidden hidden hidden hidden
Less: Marketable securities hidden hidden hidden hidden hidden
Enterprise value (EV) hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

1 Data adjusted for splits and stock dividends.
2 Close price on the filing date of Regeneron Pharmaceuticals Inc.’s Annual Report.

Item Description The company
EV Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. Regeneron Pharmaceuticals Inc.’s EV declined from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level.